Institute of Pathology, Ludwig Maximilians University, Munich, Germany.
Department of Biomedical Sciences and Cornell Stem Cell Program, Cornell University, Ithaca, NY, USA.
Mod Pathol. 2017 Sep;30(9):1241-1250. doi: 10.1038/modpathol.2017.53. Epub 2017 Jun 30.
Recently it has been reported that serous tubal intraepithelial carcinoma (STIC), the likely precursor of ovarian/extra-uterine high-grade serous carcinoma, are frequently located in the vicinity of tubal-peritoneal junctions, consistent with the cancer-prone features of many epithelial transitional regions. To test if p53 (aka TP53)-signatures and secretory cell outgrowths (SCOUTs) also localize to tubal-peritoneal junctions, we examined these lesions in the fallopian tubes of patients undergoing salpingo-oophorectomy for sporadic high-grade serous carcinomas or as a prophylactic procedure for carriers of familial BRCA1 or 2 mutations. STICs were located closest to the tubal-peritoneal junctions with an average distance of 1.31 mm, while SCOUTs were not detected in the fimbriated end of the fallopian tube. As many epithelial transitional regions contain stem cells, we also determined the expression of stem cell markers in the normal fallopian tube, tubal intraepithelial lesions and high-grade serous carcinomas. Of those, LEF1 was consistently expressed in the tubal-peritoneal junctions and all lesions, independent of p53 status. All SCOUTs demonstrated strong nuclear expression of β-catenin consistent with the LEF1 participation in the canonical WNT pathway. However, β-catenin was preferentially located in the cytoplasm of cells comprising STICs and p53 signatures, suggesting WNT-independent function of LEF1 in those lesions. Both frequency of LEF1 expression and β-catenin nuclear expression correlated with the worst 5-year patient survival, supporting important role of both proteins in high-grade serous carcinoma. Taken together, our findings suggest the existence of stem cell niche within the tubal-peritoneal junctions. Furthermore, they support the notion that the pathogenesis of SCOUTs is distinct from that of STICs and p53 signatures. The location and discrete patterns of LEF1 and β-catenin expression may serve as highly sensitive and reliable ancillary markers for the detection and differential diagnosis of tubal intraepithelial lesions.
最近有报道称,输卵管上皮内癌(STIC),可能是卵巢/输卵管高级别浆液性癌的前体,常位于输卵管-腹膜交界处附近,这与许多上皮过渡区域的癌症易感性特征一致。为了测试 p53(又称 TP53)特征和分泌细胞生长(SCOUT)是否也定位于输卵管-腹膜交界处,我们检查了在因散发性高级别浆液性癌而接受输卵管卵巢切除术的患者的输卵管中以及作为家族性 BRCA1 或 2 突变携带者的预防性手术中这些病变。STIC 位于离输卵管-腹膜交界处最近的位置,平均距离为 1.31mm,而 SCOUT 未在输卵管的伞端检测到。由于许多上皮过渡区域包含干细胞,我们还确定了正常输卵管、输卵管上皮内病变和高级别浆液性癌中干细胞标志物的表达。在这些标志物中,LEF1 始终在输卵管-腹膜交界处和所有病变中表达,与 p53 状态无关。所有 SCOUT 均表现出 β-连环蛋白的强烈核表达,这与 LEF1 参与经典 WNT 途径一致。然而,β-连环蛋白优先位于构成 STIC 和 p53 特征的细胞的细胞质中,这表明 LEF1 在这些病变中具有 WNT 非依赖性功能。LEF1 表达的频率和 β-连环蛋白核表达均与患者最差的 5 年生存率相关,这支持了这两种蛋白在高级别浆液性癌中的重要作用。总之,我们的发现表明在输卵管-腹膜交界处存在干细胞龛。此外,它们支持这样一种观点,即 SCOUT 的发病机制与 STIC 和 p53 特征不同。LEF1 和 β-连环蛋白表达的位置和离散模式可作为检测和鉴别输卵管上皮内病变的高度敏感和可靠辅助标志物。